(Q74059498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

C Efthymiopoulos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S L Bramer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Maroli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

33 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9433650%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-199700331-00003

8 November 2019

exact match

0 references

cites work

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers

1 reference

12 December 2020

Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829

1 reference

12 December 2020

In vitro activity of OPC-17116

1 reference

12 December 2020

Clinical pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Ofloxacin clinical pharmacokinetics

1 reference

12 December 2020

The clinical pharmacokinetics of levofloxacin

1 reference

12 December 2020

Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.

1 reference

12 December 2020

Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116

1 reference

12 December 2020

Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin

1 reference

12 December 2020

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones

1 reference

12 December 2020

Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria

1 reference

12 December 2020

Tentative interpretive criteria for testing the susceptibility of Streptococcus pneumoniae to eight fluoroquinolones

1 reference

12 December 2020

Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020